{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:58:41Z","timestamp":1780462721404,"version":"3.54.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"DOI":"10.1007\/s40520-022-02148-2","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T06:02:22Z","timestamp":1654063342000},"page":"2139-2147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Plasma p-tau181 associated with structural changes in mild cognitive impairment"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4633-3340","authenticated-orcid":false,"given":"Fardin","family":"Nabizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Balabandian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Pourhamzeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Alzheimer\u2019s disease Neuroimaging Initiative (ADNI)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"2148_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"CA Lane","year":"2018","unstructured":"Lane CA, Hardy J, Schott JM (2018) Alzheimer\u2019s disease. Eur J Neurol 25:59\u201370. https:\/\/doi.org\/10.1111\/ene.13439","journal-title":"Eur J Neurol"},{"key":"2148_CR2","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s10571-020-00906-2","volume":"41","author":"M Pourhamzeh","year":"2020","unstructured":"Pourhamzeh M, Joghataei MT, Mehrabi S et al (2020) The interplay of Tau Protein and \u03b2-Amyloid: while tauopathy spreads more profoundly than amyloidopathy, both processes are almost equally pathogenic. Cell Mol Neurobiol 41:1339\u20131354","journal-title":"Cell Mol Neurobiol"},{"key":"2148_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.mcna.2018.10.009","volume":"103","author":"A Atri","year":"2019","unstructured":"Atri A (2019) The Alzheimer\u2019s disease clinical spectrum: diagnosis and management. Med Clin North Am 103:263\u2013293. https:\/\/doi.org\/10.1016\/j.mcna.2018.10.009","journal-title":"Med Clin North Am"},{"key":"2148_CR4","doi-asserted-by":"publisher","first-page":"175628641988881","DOI":"10.1177\/1756286419888819","volume":"12","author":"M Mil\u00e0-Alom\u00e0","year":"2019","unstructured":"Mil\u00e0-Alom\u00e0 M, Su\u00e1rez-Calvet M, Molinuevo JL (2019) Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer\u2019s disease. Ther Adv Neurol Disord 12:1756286419888819\u20131756286419888819. https:\/\/doi.org\/10.1177\/1756286419888819","journal-title":"Ther Adv Neurol Disord"},{"key":"2148_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/wco.0000000000000345","volume":"29","author":"M Bozzali","year":"2016","unstructured":"Bozzali M, Serra L, Cercignani M (2016) Quantitative MRI to understand Alzheimer\u2019s disease pathophysiology. Curr Opin Neurol 29:437\u2013444. https:\/\/doi.org\/10.1097\/wco.0000000000000345","journal-title":"Curr Opin Neurol"},{"key":"2148_CR6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s00415-018-9016-3","volume":"266","author":"A Chandra","year":"2019","unstructured":"Chandra A, Dervenoulas G, Politis M et al (2019) Magnetic resonance imaging in Alzheimer\u2019s disease and mild cognitive impairment. J Neurol 266:1293\u20131302. https:\/\/doi.org\/10.1007\/s00415-018-9016-3","journal-title":"J Neurol"},{"key":"2148_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neulet.2006.07.029","volume":"406","author":"A Duarte","year":"2006","unstructured":"Duarte A, Hayasaka S, Du A et al (2006) Volumetric correlates of memory and executive function in normal elderly, mild cognitive impairment and Alzheimer\u2019s disease. Neurosci Lett 406:60\u201365. https:\/\/doi.org\/10.1016\/j.neulet.2006.07.029","journal-title":"Neurosci Lett"},{"key":"2148_CR8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00234-010-0795-1","volume":"53","author":"X Li","year":"2011","unstructured":"Li X, Coyle D, Maguire L et al (2011) Gray matter concentration and effective connectivity changes in Alzheimer\u2019s disease: a longitudinal structural MRI study. Neuroradiology 53:733\u2013748. https:\/\/doi.org\/10.1007\/s00234-010-0795-1","journal-title":"Neuroradiology"},{"key":"2148_CR9","doi-asserted-by":"publisher","first-page":"101843","DOI":"10.1016\/j.nicl.2019.101843","volume":"23","author":"M Mitolo","year":"2019","unstructured":"Mitolo M, Stanzani-Maserati M, Capellari S et al (2019) Predicting conversion from mild cognitive impairment to Alzheimer\u2019s disease using brain (1)H-MRS and volumetric changes: a two- year retrospective follow-up study. NeuroImage Clinical 23:101843\u2013101843. https:\/\/doi.org\/10.1016\/j.nicl.2019.101843","journal-title":"NeuroImage Clinical"},{"key":"2148_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s12640-018-9895-1","volume":"34","author":"SH Xin","year":"2018","unstructured":"Xin SH, Tan L, Cao X et al (2018) Clearance of amyloid beta and tau in Alzheimer\u2019s disease: from mechanisms to therapy. Neurotox Res 34:733\u2013748. https:\/\/doi.org\/10.1007\/s12640-018-9895-1","journal-title":"Neurotox Res"},{"key":"2148_CR11","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3233\/JAD-170680","volume":"62","author":"M Bjerke","year":"2018","unstructured":"Bjerke M, Engelborghs S (2018) Cerebrospinal fluid biomarkers for early and differential Alzheimer\u2019s disease diagnosis. J Alzheimers Dis 62:1199\u20131209. https:\/\/doi.org\/10.3233\/JAD-170680","journal-title":"J Alzheimers Dis"},{"key":"2148_CR12","doi-asserted-by":"publisher","first-page":"S611","DOI":"10.3233\/jad-179935","volume":"64","author":"W Gulisano","year":"2018","unstructured":"Gulisano W, Maugeri D, Baltrons MA et al (2018) Role of amyloid-\u03b2 and Tau proteins in Alzheimer\u2019s disease: confuting the amyloid cascade. J Alzheimers Dis 64:S611-s631. https:\/\/doi.org\/10.3233\/jad-179935","journal-title":"J Alzheimers Dis"},{"key":"2148_CR13","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2174\/1567205016666190321163438","volume":"16","author":"L Pinheiro","year":"2019","unstructured":"Pinheiro L, Faustino C (2019) Therapeutic strategies targeting amyloid-\u03b2 in Alzheimer\u2019s disease. Curr Alzheimer Res 16:418\u2013452. https:\/\/doi.org\/10.2174\/1567205016666190321163438","journal-title":"Curr Alzheimer Res"},{"key":"2148_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-15436-0","volume":"11","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Stomrud E, Smith R et al (2020) Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer\u2019s disease. Nat Commun 11:1\u201312","journal-title":"Nat Commun"},{"key":"2148_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30071-5","author":"TK Karikari","year":"2020","unstructured":"Karikari TK, Pascoal TA, Ashton NJ et al (2020) Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(20)30071-5","journal-title":"Lancet Neurol"},{"key":"2148_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0755-1","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Mattsson N, Palmqvist S et al (2020) Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia. Nat Med. https:\/\/doi.org\/10.1038\/s41591-020-0755-1","journal-title":"Nat Med"},{"key":"2148_CR17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL et al (2018) High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease. Nature 554:249\u2013254","journal-title":"Nature"},{"key":"2148_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/brain\/awy347","volume":"142","author":"J-C Park","year":"2019","unstructured":"Park J-C, Han S-H, Yi D et al (2019) Plasma tau\/amyloid-\u03b21\u201342 ratio predicts brain tau deposition and neurodegeneration in Alzheimer\u2019s disease. Brain 142:771\u2013786","journal-title":"Brain"},{"key":"2148_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13024-017-0206-8","volume":"12","author":"H Tatebe","year":"2017","unstructured":"Tatebe H, Kasai T, Ohmichi T et al (2017) Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer\u2019s disease and down syndrome. Mol Neurodegener 12:63\u201363. https:\/\/doi.org\/10.1186\/s13024-017-0206-8","journal-title":"Mol Neurodegener"},{"key":"2148_CR20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","volume":"14","author":"MM Mielke","year":"2018","unstructured":"Mielke MM, Hagen CE, Xu J et al (2018) Plasma phospho-tau181 increases with Alzheimer\u2019s disease clinical severity and is associated with tau-and amyloid-positron emission tomography. Alzheimers Dement 14:989\u2013997","journal-title":"Alzheimers Dement"},{"key":"2148_CR21","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3233\/JAD-170810","volume":"61","author":"C-C Yang","year":"2018","unstructured":"Yang C-C, Chiu M-J, Chen T-F et al (2018) Assay of plasma phosphorylated tau protein (threonine 181) and total tau protein in early-stage Alzheimer\u2019s disease. J Alzheimers Dis 61:1323\u20131332","journal-title":"J Alzheimers Dis"},{"key":"2148_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab073","author":"FZ Lussier","year":"2021","unstructured":"Lussier FZ, Benedet AL, Therriault J et al (2021) Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcab073","journal-title":"Brain Commun"},{"key":"2148_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-022-00908-7","author":"F Nabizadeh","year":"2022","unstructured":"Nabizadeh F, Pourhamzeh M, Khani S et al (2022) Plasma phosphorylated-tau181 levels reflect white matter microstructural changes across Alzheimer\u2019s disease progression. Metab Brain Dis. https:\/\/doi.org\/10.1007\/s11011-022-00908-7","journal-title":"Metab Brain Dis"},{"key":"2148_CR24","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/wnl.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M et al (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34:939\u2013944. https:\/\/doi.org\/10.1212\/wnl.34.7.939","journal-title":"Neurology"},{"key":"2148_CR25","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"RC Petersen","year":"2010","unstructured":"Petersen RC, Aisen PS, Beckett LA et al (2010) Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology 74:201\u2013209. https:\/\/doi.org\/10.1212\/WNL.0b013e3181cb3e25","journal-title":"Neurology"},{"key":"2148_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neuroimage.2011.02.076","volume":"57","author":"M Reuter","year":"2011","unstructured":"Reuter M, Fischl B (2011) Avoiding asymmetry-induced bias in longitudinal image processing. Neuroimage 57:19\u201321. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.02.076","journal-title":"Neuroimage"},{"key":"2148_CR27","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/hbm.20312","volume":"28","author":"A Bischoff-Grethe","year":"2007","unstructured":"Bischoff-Grethe A, Ozyurt IB, Busa E et al (2007) A technique for the deidentification of structural brain MR images. Hum Brain Mapp 28:892\u2013903. https:\/\/doi.org\/10.1002\/hbm.20312","journal-title":"Hum Brain Mapp"},{"key":"2148_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/apnr.2000.9231","volume":"13","author":"VC Pangman","year":"2000","unstructured":"Pangman VC, Sloan J, Guse L (2000) An examination of psychometric properties of the Mini-Mental State Examination and the Standardized Mini-Mental State Examination: Implications for clinical practice. Appl Nurs Res 13:209\u2013213. https:\/\/doi.org\/10.1053\/apnr.2000.9231","journal-title":"Appl Nurs Res"},{"key":"2148_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d: A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198. https:\/\/doi.org\/10.1016\/0022-3956(75)90026-6","journal-title":"J Psychiatr Res"},{"key":"2148_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1602\/neurorx.1.2.226","volume":"1","author":"MC Irizarry","year":"2004","unstructured":"Irizarry MC (2004) Biomarkers of Alzheimer disease in plasma. NeuroRx 1:226\u2013234. https:\/\/doi.org\/10.1602\/neurorx.1.2.226","journal-title":"NeuroRx"},{"key":"2148_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11910-019-1006-z","volume":"19","author":"L Krajcovicova","year":"2019","unstructured":"Krajcovicova L, Klobusiakova P, Rektorova I (2019) Gray matter changes in Parkinson\u2019s and Alzheimer\u2019s disease and relation to cognition. Curr Neurol Neurosci Rep 19:85\u201385. https:\/\/doi.org\/10.1007\/s11910-019-1006-z","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2148_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00401-020-02195-x","volume":"140","author":"J Lantero Rodriguez","year":"2020","unstructured":"Lantero Rodriguez J, Karikari TK et al (2020) Plasma p-tau181 accurately predicts Alzheimer\u2019s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline. Acta Neuropathol 140:267\u2013278. https:\/\/doi.org\/10.1007\/s00401-020-02195-x","journal-title":"Acta Neuropathol"},{"key":"2148_CR33","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1001\/jamaneurol.2017.1359","volume":"74","author":"MM Mielke","year":"2017","unstructured":"Mielke MM, Hagen CE, Wennberg AMV et al (2017) Association of plasma total tau level with cognitive decline and risk of mild cognitive impairment or dementia in the Mayo Clinic study on aging. JAMA Neurol 74:1073\u20131080. https:\/\/doi.org\/10.1001\/jamaneurol.2017.1359","journal-title":"JAMA Neurol"},{"key":"2148_CR34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","volume":"26","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Mattsson N, Palmqvist S et al (2020) Plasma P-tau181 in Alzheimer\u2019s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer\u2019s dementia. Nat Med 26:379\u2013386. https:\/\/doi.org\/10.1038\/s41591-020-0755-1","journal-title":"Nat Med"},{"key":"2148_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/108190","author":"AM Stranahan","year":"2010","unstructured":"Stranahan AM, Mattson MP (2010) Selective vulnerability of neurons in layer II of the entorhinal cortex during aging and Alzheimer\u2019s disease. Neural Plast. https:\/\/doi.org\/10.1155\/2010\/108190","journal-title":"Neural Plast"},{"key":"2148_CR36","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/brain\/awr020","volume":"134","author":"M Amanzio","year":"2011","unstructured":"Amanzio M, Torta DME, Sacco K et al (2011) Unawareness of deficits in Alzheimer\u2019s disease: role of the cingulate cortex. Brain 134:1061\u20131076. https:\/\/doi.org\/10.1093\/brain\/awr020","journal-title":"Brain"},{"key":"2148_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep42370","volume":"7","author":"C Criscuolo","year":"2017","unstructured":"Criscuolo C, Fontebasso V, Middei S et al (2017) Entorhinal cortex dysfunction can be rescued by inhibition of microglial RAGE in an Alzheimer\u2019s disease mouse model. Sci Rep 7:1\u201315. https:\/\/doi.org\/10.1038\/srep42370","journal-title":"Sci Rep"},{"key":"2148_CR38","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/archneurol.2009.130","volume":"66","author":"N Scarmeas","year":"2009","unstructured":"Scarmeas N, Honig LS, Choi H et al (2009) Seizures in Alzheimer disease: who, when, and how common? Arch Neurol 66:992\u2013997. https:\/\/doi.org\/10.1001\/archneurol.2009.130","journal-title":"Arch Neurol"},{"key":"2148_CR39","doi-asserted-by":"publisher","first-page":"9572","DOI":"10.1073\/pnas.1133381100","volume":"100","author":"JJ Palop","year":"2003","unstructured":"Palop JJ, Jones B, Kekonius L et al (2003) Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer\u2019s disease-related cognitive deficits. Proc Natl Acad Sci USA 100:9572\u20139577. https:\/\/doi.org\/10.1073\/pnas.1133381100","journal-title":"Proc Natl Acad Sci USA"},{"key":"2148_CR40","doi-asserted-by":"publisher","first-page":"8336","DOI":"10.1007\/s12035-019-01671-0","volume":"56","author":"J Therriault","year":"2019","unstructured":"Therriault J, Wang S, Mathotaarachchi S et al (2019) Rostral-caudal hippocampal functional convergence is reduced across the Alzheimer\u2019s disease spectrum. Mol Neurobiol 56:8336\u20138344. https:\/\/doi.org\/10.1007\/s12035-019-01671-0","journal-title":"Mol Neurobiol"},{"key":"2148_CR41","doi-asserted-by":"publisher","first-page":"e12873","DOI":"10.1111\/acel.12873","volume":"18","author":"R Belfiore","year":"2019","unstructured":"Belfiore R, Rodin A, Ferreira E et al (2019) Temporal and regional progression of Alzheimer\u2019s disease-like pathology in 3xTg-AD mice. Aging Cell 18:e12873\u2013e12873. https:\/\/doi.org\/10.1111\/acel.12873","journal-title":"Aging Cell"},{"key":"2148_CR42","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrn3338","volume":"13","author":"C Ranganath","year":"2012","unstructured":"Ranganath C, Ritchey M (2012) Two cortical systems for memory-guided behaviour. Nat Rev Neurosci 13:713\u2013726. https:\/\/doi.org\/10.1038\/nrn3338","journal-title":"Nat Rev Neurosci"},{"key":"2148_CR43","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/ar.21493","volume":"295","author":"SJ Greene","year":"2012","unstructured":"Greene SJ, Killiany RJ (2012) Hippocampal subregions are differentially affected in the progression to Alzheimer\u2019s disease. Anatomical Record (Hoboken, NJ: 2007) 295:132\u2013140. https:\/\/doi.org\/10.1002\/ar.21493","journal-title":"Anatomical Record (Hoboken, NJ: 2007)"},{"key":"2148_CR44","doi-asserted-by":"publisher","first-page":"108669","DOI":"10.1016\/j.jneumeth.2020.108669","volume":"337","author":"G Uysal","year":"2020","unstructured":"Uysal G, Ozturk M (2020) Hippocampal atrophy based Alzheimer\u2019s disease diagnosis via machine learning methods. J Neurosci Methods 337:108669\u2013108669. https:\/\/doi.org\/10.1016\/j.jneumeth.2020.108669","journal-title":"J Neurosci Methods"},{"key":"2148_CR45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ana.92.abs","volume":"49","author":"D Chan","year":"2001","unstructured":"Chan D, Fox NC, Scahill RI et al (2001) Patterns of temporal lobe atrophy in semantic dementia and Alzheimer\u2019s disease. Ann Neurol 49:433\u2013442. https:\/\/doi.org\/10.1002\/ana.92.abs","journal-title":"Ann Neurol"},{"key":"2148_CR46","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fnagi.2019.00147","volume":"11","author":"JS Lee","year":"2019","unstructured":"Lee JS, Park YH, Park S et al (2019) Distinct brain regions in physiological and pathological brain aging. Front Aging Neurosci 11:147\u2013147. https:\/\/doi.org\/10.3389\/fnagi.2019.00147","journal-title":"Front Aging Neurosci"},{"key":"2148_CR47","volume-title":"Cerebrospinal fluid in clinical neurology","author":"E Niemantsverdriet","year":"2015","unstructured":"Niemantsverdriet E, Struyfs H, Duits F et al (2015) Cerebrospinal fluid in clinical neurology. Springer Science and Business Media LLC Berlin, Germany"},{"key":"2148_CR48","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1001\/jamaneurol.2015.0202","volume":"72","author":"R Tarawneh","year":"2015","unstructured":"Tarawneh R, Head D, Allison S et al (2015) Cerebrospinal fluid markers of neurodegeneration and rates of brain atrophy in early Alzheimer disease. JAMA Neurol 72:656\u2013665. https:\/\/doi.org\/10.1001\/jamaneurol.2015.0202","journal-title":"JAMA Neurol"},{"key":"2148_CR49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0304-3940(99)00617-5","volume":"273","author":"N Andreasen","year":"1999","unstructured":"Andreasen N, Minthon L, Vanmechelen E et al (1999) Cerebrospinal fluid tau and Abeta42 as predictors of development of Alzheimer\u2019s disease in patients with mild cognitive impairment. Neurosci Lett 273:5\u20138. https:\/\/doi.org\/10.1016\/s0304-3940(99)00617-5","journal-title":"Neurosci Lett"},{"key":"2148_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s40120-017-0073-9","volume":"6","author":"K Blennow","year":"2017","unstructured":"Blennow K (2017) A review of fluid biomarkers for Alzheimer\u2019s disease: moving from CSF to blood. Neurol Ther 6:15\u201324. https:\/\/doi.org\/10.1007\/s40120-017-0073-9","journal-title":"Neurol Ther"},{"key":"2148_CR51","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3233\/JAD-2010-1401","volume":"20","author":"M Lehmann","year":"2010","unstructured":"Lehmann M, Rohrer JD, Clarkson MJ et al (2010) Reduced cortical thickness in the posterior cingulate gyrus is characteristic of both typical and atypical alzheimer\u2019s disease. J Alzheimers Dis 20:587\u2013598. https:\/\/doi.org\/10.3233\/JAD-2010-1401","journal-title":"J Alzheimers Dis"},{"key":"2148_CR52","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41398-021-01476-7","volume":"11","author":"SD Chen","year":"2021","unstructured":"Chen SD, Huang YY, Shen XN et al (2021) Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer\u2019s disease. Transl Psychiatry 11:356. https:\/\/doi.org\/10.1038\/s41398-021-01476-7","journal-title":"Transl Psychiatry"},{"key":"2148_CR53","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1093\/cercor\/bhj105","volume":"16","author":"BF Jones","year":"2006","unstructured":"Jones BF, Barnes J, Uylings HBM et al (2006) Differential regional atrophy of the cingulate gyrus in Alzheimer disease: a volumetric MRI study. Cereb Cortex 16:1701\u20131708. https:\/\/doi.org\/10.1093\/cercor\/bhj105","journal-title":"Cereb Cortex"},{"key":"2148_CR54","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejrad.2017.07.014","volume":"94","author":"L Rice","year":"2017","unstructured":"Rice L, Bisdas S (2017) The diagnostic value of FDG and amyloid PET in Alzheimer\u2019s disease-a systematic review. Eur J Radiol 94:16\u201324. https:\/\/doi.org\/10.1016\/j.ejrad.2017.07.014","journal-title":"Eur J Radiol"},{"key":"2148_CR55","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1001\/archneur.58.3.480","volume":"58","author":"ALW Bokde","year":"2001","unstructured":"Bokde ALW, Pietrini P, Ib\u00e1\u00f1ez V et al (2001) The effect of brain atrophy on cerebral hypometabolism in the visual variant of Alzheimer disease. Arch Neurol 58:480\u2013486. https:\/\/doi.org\/10.1001\/archneur.58.3.480","journal-title":"Arch Neurol"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-022-02148-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-022-02148-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-022-02148-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T16:27:13Z","timestamp":1662827233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-022-02148-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["2148"],"URL":"https:\/\/doi.org\/10.1007\/s40520-022-02148-2","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]},"assertion":[{"value":"19 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Since the data in this paper were obtained from the ADNI database (adni.loni.usc.edu), it does not include any research involving human or animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This manuscript has been approved for publication by all authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}